This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07754/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07754/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07754/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07754/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07754
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07754 n11:DB07754
dcterms:title
N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid
adms:identifier
n4:99444225 n7:DB07754 n8:FBD n13:25113157
n5:IUPAC-Name
n6:271B630F-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6315-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6314-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6311-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6312-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6313-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B630D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B630E-363D-11E5-9242-09173F13E4C5 n6:271B630B-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B630C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B631B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B631C-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6316-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6317-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6319-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6318-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B631A-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6321-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6323-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6324-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6320-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B631F-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6322-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6310-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B631D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B631E-363D-11E5-9242-09173F13E4C5